Literature DB >> 25655897

Angiotensin II receptor blocker as a novel therapy in acute lung injury induced by avian influenza A H5N1 virus infection in mouse.

YiWu Yan1, Qiang Liu, Ning Li, JianChao Du, Xiao Li, Chang Li, NingYi Jin, ChengYu Jiang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25655897      PMCID： PMC7088914          DOI： 10.1007/s11427-015-4814-7

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN： 1674-7305            Impact factor:   6.038


× No keyword cloud information.
Supplementary material, approximately 356 KB.
  13 in total

1.  Airborne transmission of influenza A/H5N1 virus between ferrets.

Authors:  Sander Herfst; Eefje J A Schrauwen; Martin Linster; Salin Chutinimitkul; Emmie de Wit; Vincent J Munster; Erin M Sorrell; Theo M Bestebroer; David F Burke; Derek J Smith; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Science       Date:  2012-06-22       Impact factor: 47.728

2.  Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes.

Authors:  Eric M Mortensen; Brandy Nakashima; John Cornell; Laurel A Copeland; Mary Jo Pugh; Antonio Anzueto; Chester Good; Marcos I Restrepo; John R Downs; Christopher R Frei; Michael J Fine
Journal:  Clin Infect Dis       Date:  2012-08-23       Impact factor: 9.079

Review 3.  Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases.

Authors:  S Kim; H Iwao
Journal:  Pharmacol Rev       Date:  2000-03       Impact factor: 25.468

4.  Nonpeptide antagonists of AT1 receptor for angiotensin II delay the onset of acute respiratory distress syndrome.

Authors:  Silvina Raiden; Karen Nahmod; Víctor Nahmod; Guillermo Semeniuk; Yanina Pereira; Clarisa Alvarez; Mirta Giordano; Jorge R Geffner
Journal:  J Pharmacol Exp Ther       Date:  2002-10       Impact factor: 4.030

Review 5.  Innate immune responses to influenza A H5N1: friend or foe?

Authors:  Joseph Sriyal Malik Peiris; Chung Yan Cheung; Connie Yin Hung Leung; John Malcolm Nicholls
Journal:  Trends Immunol       Date:  2009-10-26       Impact factor: 16.687

6.  Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats.

Authors:  Y Inada; T Wada; Y Shibouta; M Ojima; T Sanada; K Ohtsuki; K Itoh; K Kubo; Y Kohara; T Naka
Journal:  J Pharmacol Exp Ther       Date:  1994-03       Impact factor: 4.030

7.  Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets.

Authors:  Masaki Imai; Tokiko Watanabe; Masato Hatta; Subash C Das; Makoto Ozawa; Kyoko Shinya; Gongxun Zhong; Anthony Hanson; Hiroaki Katsura; Shinji Watanabe; Chengjun Li; Eiryo Kawakami; Shinya Yamada; Maki Kiso; Yasuo Suzuki; Eileen A Maher; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Nature       Date:  2012-05-02       Impact factor: 49.962

8.  Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients.

Authors:  Fengming Huang; Jing Guo; Zhen Zou; Jun Liu; Bin Cao; Shuyang Zhang; Hui Li; Wei Wang; Miaomiao Sheng; Song Liu; Jingcao Pan; Changjun Bao; Mei Zeng; Haixia Xiao; Guirong Qian; Xinjun Hu; Yuanting Chen; Yu Chen; Yan Zhao; Qiang Liu; Huandi Zhou; Jindong Zhu; Hainv Gao; Shigui Yang; Xiaoli Liu; Shufa Zheng; Jiezuan Yang; Hongyan Diao; Hongcui Cao; Ying Wu; Min Zhao; Shuguang Tan; Dan Guo; Xiliang Zhao; Yicong Ye; Wei Wu; Yingchun Xu; Josef M Penninger; Dangsheng Li; George F Gao; Chengyu Jiang; Lanjuan Li
Journal:  Nat Commun       Date:  2014-05-06       Impact factor: 14.919

Review 9.  The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice.

Authors:  Yumiko Imai; Keiji Kuba; Josef M Penninger
Journal:  Exp Physiol       Date:  2008-04-10       Impact factor: 2.969

10.  Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections.

Authors:  Zhen Zou; Yiwu Yan; Yuelong Shu; Rongbao Gao; Yang Sun; Xiao Li; Xiangwu Ju; Zhu Liang; Qiang Liu; Yan Zhao; Feng Guo; Tian Bai; Zongsheng Han; Jindong Zhu; Huandi Zhou; Fengming Huang; Chang Li; Huijun Lu; Ning Li; Dangsheng Li; Ningyi Jin; Josef M Penninger; Chengyu Jiang
Journal:  Nat Commun       Date:  2014-05-06       Impact factor: 14.919
View more
  24 in total

Review 1.  Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola.

Authors:  David S Fedson
Journal:  Ann Transl Med       Date:  2016-11

Review 2.  A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1/ACE2 imbalance.

Authors:  Krishna Sriram; Paul A Insel
Journal:  Br J Pharmacol       Date:  2020-05-22       Impact factor: 8.739

3.  Discontinuation of Antihypertensive Medications on the Outcome of Hospitalized Patients With Severe Acute Respiratory Syndrome-Coronavirus 2.

Authors:  Sandeep Singh; Annette K Offringa-Hup; Susan J J Logtenberg; Paul D Van der Linden; Wilbert M T Janssen; Hubertina Klein; Femke Waanders; Suat Simsek; Cornelis P C de Jager; Paul Smits; Machteld van der Feltz; Gerrit Jan Beumer; Christine Widrich; Martijn Nap; Sara-Joan Pinto-Sietsma
Journal:  Hypertension       Date:  2021-06-09       Impact factor: 10.190

4.  miRNA-200c-3p is crucial in acute respiratory distress syndrome.

Authors:  Qiang Liu; Jianchao Du; Xuezhong Yu; Jun Xu; Fengming Huang; Xiaoyun Li; Cong Zhang; Xiao Li; Jiahui Chang; Daozhen Shang; Yan Zhao; Mingyao Tian; Huijun Lu; Jiantao Xu; Chang Li; Huadong Zhu; Ningyi Jin; Chengyu Jiang
Journal:  Cell Discov       Date:  2017-06-27       Impact factor: 10.849

Review 5.  Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.

Authors:  Wentao Ni; Xiuwen Yang; Deqing Yang; Jing Bao; Ran Li; Yongjiu Xiao; Chang Hou; Haibin Wang; Jie Liu; Donghong Yang; Yu Xu; Zhaolong Cao; Zhancheng Gao
Journal:  Crit Care       Date:  2020-07-13       Impact factor: 9.097

6.  Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation.

Authors:  Jiawei Chen; Quanlong Jiang; Xian Xia; Kangping Liu; Zhengqing Yu; Wanyu Tao; Wenxuan Gong; Jing-Dong J Han
Journal:  Aging Cell       Date:  2020-06-19       Impact factor: 9.304

7.  National common metrics for the NIH Clinical and Translational Science Award Institutions: A signal of the transformation of the American biomedical research enterprise.

Authors:  Harry P Selker
Journal:  J Clin Transl Sci       Date:  2019-10-08

Review 8.  Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS-CoV-2: A double-edged sword?

Authors:  Tiantian Yan; Rong Xiao; Guoan Lin
Journal:  FASEB J       Date:  2020-04-19       Impact factor: 5.191

9.  COVID-19 and Renin Angiotensin Blockers: Current Evidence and Recommendations.

Authors:  Franz H Messerli; George C M Siontis; Emrush Rexhaj
Journal:  Circulation       Date:  2020-04-13       Impact factor: 29.690

10.  Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis.

Authors:  Jiuyang Xu; Chaolin Huang; Guohui Fan; Zhibo Liu; Lianhan Shang; Fei Zhou; Yeming Wang; Jiapei Yu; Luning Yang; Ke Xie; Zhisheng Huang; Lixue Huang; Xiaoying Gu; Hui Li; Yi Zhang; Yimin Wang; Frederick G Hayden; Peter W Horby; Bin Cao; Chen Wang
Journal:  Front Med       Date:  2020-07-03       Impact factor: 9.927
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.